Search results
7 lip 2018 · Noninvasive ventilation (NIV) has become the standard of care for respiratory support in patients with ALS. NIV use has demonstrated survival benefit and improved quality of life vs standard of care.
Abstract. Amyotrophic lateral sclerosis is a progressive neuromuscular disease characterized by both lower motor neuron and upper motor neuron dysfunction. Although clinical presentations can vary, there is no cure for ALS, and the disease is universally terminal, with most patients dying of respiratory complications.
19 sty 2023 · A comprehensive, multidisciplinary approach to ALS respiratory care may minimize hospitalizations for acute respiratory failure, reduce need for emergent tracheostomy, improve patient-reported outcome measures, and facilitate developing clinical research initiatives.
28 kwi 2022 · Consequently, the most common cause of death for people with ALS is respiratory failure. To prevent this, some people in the end stages of the disease could permanently need ventilatory support. 2 Other patients may choose to undergo a tracheostomy to facilitate full-time respirator use. 2.
15 kwi 2015 · ALS leads to death in 15 to 20 months after diagnosis in 50 % of patients [2 ••], generally due to respiratory failure. An older age and bulbar involvement at onset are the main negative prognostic factors. Ten percent survives more than 10 years.
Amyotrophic Lateral Sclerosis Neurology Neuromuscular Diseases Critical Care Medicine Respiratory Failure and Ventilation. This Viewpoint describes the dearth of noninvasive ventilation for patients with amyotrophic lateral sclerosis in the US and proposes methods to increase.
16 kwi 2024 · This study aimed to systematically review the literature on non-invasive interventions for controlling breathlessness in ALS patients and their effects on (1) overall symptom control and (2) overall QOL.
